CERo Therapeutics Holdings, Inc. Common Stock share price logo

CERo Therapeutics Holdings, Inc. Common Stock

NASDAQ: CERO

Small Cap

$0.03

(+7.62%)

as on

CERo Therapeutics Holdings, Inc. Common Stock Stock Performance

as on May 2, 2026 at 6:35 am IST

  • Day's High

    $0.03
    $0.04

    33.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.02
    $26.99
    downward going graph

    33.33%

    Downside

    89866.67%

    Upside

    downward going graph

CERo Therapeutics Holdings, Inc. Common Stock share price movements today

Previous Close
$0.03
Open
$0.04
Volume
1.7M
Day's Low - High
$0.03 - $0.04
52 Week Low - High
$0.02 - $26.99

CERo Therapeutics Holdings, Inc. Common Stock Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

CERo Therapeutics Holdings, Inc. Common Stock Stock Fundamentals & Key Indicators

Check CERo Therapeutics Holdings, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2M

EPS (TTM)

-2.5

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

CERo Therapeutics Holdings, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CERo Therapeutics Holdings, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$1.2MNANA0.00%
BUY$28.8B295.08%NA-210.54%
BUY$41.3B110.54%77.5712.55%
BUY$108.7B94.28%27.9332.94%
BUY$74.1B45.73%17.2729.65%

CERo Therapeutics Holdings, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
1
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
Operating Income
0
0
-5
-4
-4
-4
-4
-4
EBITDA
0
0
-2
-4
-4
-5
-4
-
Interest Expense
-
-
0
-
0
0
0
-
Depreciation
0
0
-
-
0
0
0
0
Income Before Tax
0
0
-2
-4
-5
-5
-4
-4
Income Tax Expense
0
0
0
-4
0
-
-
-
Net Income
0
0
-2
-4
-5
-5
-4
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-439.10%
0.00%
0.00%
0.00%

CERo Therapeutics Holdings, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-1
-1
Operating Income
0
-2
-2
-18
EBITDA
0
0
-2
-17
Interest Expense
-
-
-
0
Depreciation
0
1
1
1
Income Before Tax
0
0
-2
-19
Income Tax Expense
0
0
0
-
Net Income
0
0
0
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

CERo Therapeutics Holdings, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
-2
-2
0
-5
-5
-4
-4
-4
Operating Cash Flow
0
-5
-3
-2
-4
-4
-3
-3
-3
Investing Cash Flow
-13
-
-
0
0
-
0
-
-
Financing Cash Flow
0
7
2
2
6
2
1
3
3
Change in Cash
1
2
0
0
1
-1
-1
0
0

CERo Therapeutics Holdings, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-7
-8
-19
Operating Cash Flow
-1
-5
-5
-16
Investing Cash Flow
180
0
-
0
Financing Cash Flow
-138
0
0
13
Change in Cash
41
-5
-5
-1

CERo Therapeutics Holdings, Inc. Common Stock News & Key Events

  • img

    Today's Timeline - 30 October

    Thu, 07:05 PM

    -

    CERo Therapeutics stock plummets 80% after Nasdaq delisting notice due to failure to maintain required stockholders equity.

Insights on CERo Therapeutics Holdings, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 1108.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 284.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CERO stock has moved down by -95.0%

About CERo Therapeutics Holdings, Inc. Common Stock

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
OrganisationCERo Therapeutics Holdings, Inc. Common Stock
Headquarters201 Haskins Way, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEOMr. Christopher B. Ehrlich M.B.A.
E-voting on sharesClick here to vote

Key Management of CERo Therapeutics Holdings, Inc. Common Stock

Name

Title

Mr. Christopher B. Ehrlich M.B.A.

CEO & Chair

Mr. Andrew Albert Kucharchuk M.B.A.

Chief Financial Officer

Dr. Kristen Pierce Ph.D.

Chief Development Officer

Dr. Lawrence Corey M.D.

Co-founder & Head of Scientific Advisory Board

FAQs

What is CERo Therapeutics Holdings, Inc. Common Stock share price today?

CERo Therapeutics Holdings, Inc. Common Stock share price today is $0.03 as on at the close of the market. CERo Therapeutics Holdings, Inc. Common Stock share today touched a day high of $0.04 and a low of $0.03.

What is the 52 week high and 52 week low for CERo Therapeutics Holdings, Inc. Common Stock share?

CERo Therapeutics Holdings, Inc. Common Stock share touched a 52 week high of $26.99 on and a 52 week low of $0.02 on . CERo Therapeutics Holdings, Inc. Common Stock stock price today i.e. is closed at $0.03,which is 99.89% down from its 52 week high and 50.00% up from its 52 week low.

What is CERo Therapeutics Holdings, Inc. Common Stock's market capitalisation today?

CERo Therapeutics Holdings, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in CERo Therapeutics Holdings, Inc. Common Stock Stock (CERO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CERo Therapeutics Holdings, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CERo Therapeutics Holdings, Inc. Common Stock Shares that will get you 50.0000 shares as per CERo Therapeutics Holdings, Inc. Common Stock share price of $0.03 per share as on May 2, 2026 at 1:05 am IST.

What is the minimum amount required to buy CERo Therapeutics Holdings, Inc. Common Stock Stock (CERO) from India?

Indian investors can start investing in CERo Therapeutics Holdings, Inc. Common Stock (CERO) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in CERo Therapeutics Holdings, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on CERo Therapeutics Holdings, Inc. Common Stock share’s latest price of $0.03 as on May 2, 2026 at 1:05 am IST, you will get 333.3333 shares of CERo Therapeutics Holdings, Inc. Common Stock. Learn more about fractional shares .